Beam Therapeutics (NASDAQ:BEAM) President Giuseppe Ciaramella Sells 11,810 Shares

Chronological Source Flow
Back

AI Fusion Summary

On April 1, Beam Therapeutics insiders sold shares under Rule 10b5-1 plans: President Ciaramella sold 11,810 shares ($24.58 each) for $290,289.80, Christine Bellon sold 5,956 shares for $146,398.48, Amy Simon sold 6,700 shares for $164,686.00, reducing ownership by 5.13%, 5.15%, 6.12%; stock fell 1.7%.
#BEAM_THERAPEUTICS #INSIDER_TRADES #RULE_10B5_1 #TAX_WITHHOLDING #STOCK_PRICE_DROP
07/04 12:07 defenseworld.net
3 Πηγές

Beam Therapeutics (NASDAQ:BEAM) President Giuseppe Ciaramella Sells 11,810 Shares

Beam TherapeuticsGiuseppe Ciaramellashare saleSEC filingRule 10b5‑1equity awards
07/04 12:40 defenseworld.net

Beam Therapeutics (NASDAQ:BEAM) Insider Christine Bellon Sells 5,956 Shares

POLITICSINSIDER TRADESCOMPANIES
07/04 12:40 defenseworld.net

Beam Therapeutics (NASDAQ:BEAM) Insider Amy Simon Sells 6,700 Shares

POLITICSINSIDER TRADESCOMPANIES
Comments
Loading...
0